Orobalin (Cyanocobalamin)

Cyanocobalamin, the active ingredient in Orobalin, is a cobalamin presented as an oral dosage form for oral use. It treats vitamin B12 deficiency and related conditions such as pernicious anemia, supporting normal red blood cell formation, DNA synthesis, and neurological function in adults and children.

GNH USA supplies Orobalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution. The company adheres to EU GMP standards and provides comprehensive documentation for regulatory submissions.

Orobalin (cyanocobalamin) is used to address disorders of vitamin B12 metabolism and related anemic conditions.

- Vitamin B12 deficiency: restores normal serum B12 levels and alleviates fatigue, neuropathy and other deficiency‑related symptoms. - Pernicious anemia: supports erythropoiesis and reduces anemia severity in patients with intrinsic factor deficiency. - Megaloblastic anemia: corrects impaired DNA synthesis leading to improved red blood cell maturation. - Dietary insufficiency of B12: provides supplemental B12 for individuals with inadequate intake, such as vegans.

Adverse reactions to oral cyanocobalamin are generally mild, but patients should be aware of possible side effects.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Headache: transient mild headache. - Diarrhea: loose stools that resolve spontaneously. - Mild skin rash: localized erythema or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypersensitivity: swelling, difficulty breathing, or hives. - Thromboembolic events: rare clotting disorders reported in isolated cases. - Acute hemolysis: very rare rapid destruction of red blood cells.

Before initiating therapy, consider the following safety measures.

- Assess B12 status: confirm deficiency through laboratory testing. - Monitor hematologic parameters: check complete blood count periodically. - Use with caution in renal impairment: adjust monitoring as needed. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy and lactation: consult a physician before use. - Store at room temperature: keep in the original pack, protect from moisture and light.

Cyanocobalamin may interact with several medications; awareness helps prevent reduced efficacy or adverse events.

Major Interactions (Avoid): - Metformin: may decrease intestinal B12 absorption, potentially worsening deficiency. - Proton pump inhibitors: long‑term use can impair B12 absorption.

Moderate Interactions (Monitor Closely): - HIV antiretrovirals (e.g., zidovudine): may increase B12 requirement. - High‑dose folic acid: can mask hematologic signs of B12 deficiency. - Anticonvulsants (e.g., phenytoin): may affect B12 metabolism and utilization.